Selank is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide) is researched primarily for anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence. First anxiolytic peptide achieving benzodiazepine-equivalent action without any dependence, withdrawal, or amnesia — solving the fundamental safety limitation of the entire benzodiazepine drug class. It belongs to the Nootropic anxiolytic peptide category of compounds.
What Is Selank?
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide) is a Nootropic anxiolytic peptide. Developed by the Institute of Molecular Genetics (Russian Academy of Sciences) as a benzodiazepine-like anxiolytic without sedation or dependence.
First anxiolytic peptide achieving benzodiazepine-equivalent action without any dependence, withdrawal, or amnesia — solving the fundamental safety limitation of the entire benzodiazepine drug class. It has attracted significant research interest for its potential effects on anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence.
How Does Selank Produce These Benefits?
Allosterically modulates GABAA receptors and inhibits enkephalin-degrading enzymes. Influences dopaminergic and serotonergic systems while enhancing GABA-mediated neurotransmission, producing anxiolytic effects comparable to benzodiazepines without receptor downregulation, tolerance, or dependence.
This multi-pathway activity is why Selank shows potential across several different applications rather than being limited to a single use case.
Can Selank Help With Anxiety Reduction?
Research suggests Selank may support anxiety reduction through its nootropic anxiolytic peptide activity. Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions.
Protocols targeting anxiety reduction typically use 75-300 mcg administered 1-3 times daily for 5-21 days with washout periods.
Can Selank Help With Cognitive Enhancement?
Research suggests Selank may support cognitive enhancement through its nootropic anxiolytic peptide activity. Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions.
Protocols targeting cognitive enhancement typically use 75-300 mcg administered 1-3 times daily for 5-21 days with washout periods.
Can Selank Help With Stress Resilience?
Research suggests Selank may support stress resilience through its nootropic anxiolytic peptide activity. Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions.
Protocols targeting stress resilience typically use 75-300 mcg administered 1-3 times daily for 5-21 days with washout periods.
Can Selank Help With Benzodiazepine-Like Anxiolysis Without Dependence?
Research suggests Selank may support benzodiazepine-like anxiolysis without dependence through its nootropic anxiolytic peptide activity. Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions.
Protocols targeting benzodiazepine-like anxiolysis without dependence typically use 75-300 mcg administered 1-3 times daily for 5-21 days with washout periods.
Can Stacking Enhance Selank Benefits?
Pairs with Semax for enhanced cognitive and anxiolytic effects through complementary GABAergic/dopaminergic pathways.
See our Selank stacking guide for detailed combination protocols.
What Is the Bottom Line on Selank Benefits?
Selank is researched for anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence. The evidence base includes: Clinical noninferiority trial in 62 GAD patients showed similar anxiolytic action to medazepam (benzodiazepine). Multiple Russian clinical studies demonstrate efficacy. Evidence base predominantly from Russian institutions.
Selank is not fda-approved. approved in russia (2009) for generalized anxiety disorder. available as research chemical in us. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
Selank: The Anxiolytic Research Peptide
Related Reading
- Selank Dosage Guide
- Selank Side Effects
- Selank Stacking Guide
- Selank Cycle Guide
- Selank Research
- Semax Complete Guide
Calculate Your Selank Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Selank.
Open Calculator →Research-Grade Sourcing
If you're going to research Selank, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Selank?
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide) is a Nootropic anxiolytic peptide. Developed by the Institute of Molecular Genetics (Russian Academy of Sciences) as a benzodiazepine-like anxiolytic without sedation or dependence. It is researched for anxiety reduction, cognitive enhancement, stress resilience, benzodiazepine-like anxiolysis without dependence.
What is the recommended Selank dosage?
Common dosages: 75-300 mcg administered 1-3 times daily via intranasal spray. Cycle length: 5-21 days with washout periods. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of Selank?
Well-tolerated. Mild nasal irritation at application site. No amnesia, withdrawal, or dependence liability — unlike benzodiazepines.
Is Selank safe?
Selank has shown a favorable safety profile in research. Not FDA-approved. Approved in Russia (2009) for generalized anxiety disorder. Available as research chemical in US. All research should follow appropriate safety protocols.